Inhibikase Therapeutics, INC. (IKT) — DEFA14A Filings
All DEFA14A filings from Inhibikase Therapeutics, INC.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
-
Inhibikase Therapeutics Files Proxy Statement Supplement
— Jun 12, 2025 Risk: low
Inhibikase Therapeutics, Inc. filed a Definitive Additional Materials filing (DEFA14A) on June 12, 2025. This filing supplements their proxy statement, indicati -
Inhibikase Therapeutics Files Additional Proxy Materials
— Jun 21, 2024 Risk: low
Inhibikase Therapeutics, Inc. filed a Definitive Additional Materials (DEFA14A) on June 21, 2024. This filing is related to their proxy statement and indicates
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX